SOMATOM Force (Model 10742326) Computed tomography x-ray diagnostic system
FDA Device Recall #Z-1748-2018 — Class II — November 8, 2017
Recall Summary
| Recall Number | Z-1748-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 8, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Siemens Medical Solutions USA, Inc |
| Location | Malvern, PA |
| Product Type | Devices |
| Quantity | 91 |
Product Description
SOMATOM Force (Model 10742326) Computed tomography x-ray diagnostic system
Reason for Recall
There is a potential risk of unnecessary radiation exposure due to a software issue found in the CARE Dose4D algorithm implemented in Siemens Healthineers CT scanners of types SOMATOM Definition AS, SOMATOM Definition DS, SOMATOM Definition Edge, SOMATOM Definition Flash and SOMATOM Force.
Distribution Pattern
Distributed in all 50 U.S. states, the District of Columbia, Guam, and Puerto Rico.
Lot / Code Information
Serial Numbers: 75708 75765 75714 75790 75709 75607 75784 75789 75617 75550 75526 75512 75775 75567 75536 75807 75711 75716 75514 75770 75600 75794 75563 75824 75768 75510 75792 75454 75754 75755 75540 75739 75806 75808 75571 75818 75437 75500 75527 75776 75728 75475 75535 75820 75727 75481 75439 75450 75482 75760 75710 75460 75476 75588 75493 75458 75528 75467 75823 75761 75602 75487 75804 75837 75743 75787 75793 75478 75604 75805 75513 75532 75843 75555 75788 75524 75778 75515 75559 75610 75501 75570 75769 75774 75752 75799 75616 75750 75576 75845 75605
Other Recalls from Siemens Medical Solutions USA, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1175-2026 | Class II | Interventional Fluoroscopic X-Ray System: LUMIN... | Dec 29, 2025 |
| Z-1174-2026 | Class II | Interventional Fluoroscopic X-Ray System: LUMIN... | Dec 29, 2025 |
| Z-1241-2026 | Class II | NAEOTOM Alpha.Prime Software applications: s... | Dec 19, 2025 |
| Z-1240-2026 | Class II | NAEOTOM Alpha Software applications: syngo.C... | Dec 19, 2025 |
| Z-1239-2026 | Class II | SOMATOM X.ceed Software applications: syngo.... | Dec 19, 2025 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.